PRECISION BIOSCIENCES
"PRECISION BIOSCIENCES" is a word mark owned by Precision BioSciences, Inc., filed at the USPTO on November 10, 2021. It is registered and covers classes 1, 5, 42 and 44.
- Status
- Registered
- Since April 25, 2023
- Filed
- November 10, 2021
- Registered
- April 25, 2023
- Expires
- Not recorded
- Application no.
- 97117501
- Registration no.
- 7034223
- Office
- USPTO
- United States Patent and Trademark Office
- Mark type
- Word mark
- 4 classes
Who owns PRECISION BIOSCIENCES
The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.
Owner
Precision BioSciences, Inc.
DTIL · Durham, United States
Representative
Eva Gullick Frongello
Parker Poe Adams & Bernstein LLP
What the mark covers
The products and services PRECISION BIOSCIENCES is filed for, grouped by Nice class.
genome editing reagents for research purposes; Chemical, biochemical, biotechnological products intended for industry, agriculture, horticulture, namely, polypeptides for in vivo and in vitro genetic engineering, natural and engineered meganucleases and endonucleases, nucleic acid vectors, molecular scissors; chemical, biochemical, biotechnological and bacteriological products intended for research laboratories and control laboratories, namely, polypeptides for in vivo and in vitro genetic engineering; Biochemicals and biologics, namely, engineered proteins for gene regulation, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, gene modification, and gene correction, all for use in scientific research, pharmaceutical research, agricultural biotechnology, diagnostics, and industrial biotechnology; engineered proteins for use in scientific research and analysis relating to genetic diseases, gene therapy, and cell therapy; biochemicals and biologics, namely, engineered nucleic acids, viral vectors, non-viral vectors, gene therapy vectors, gene editing vectors, genetically modified cells, engineered proteins for multiplexed gene editing, mRNA and recombinant adeno-associated virus (AAV) vectors for delivery of therapeutic DNA or mRNA sequences to cells, antibody preparations, CAR T-cell preparations, T-cell preparations, B-cell preparations, Treg preparations, and NK cell preparations, all for use in scientific research and analysis and diagno
pharmaceutical preparations, namely, cell therapy products utilizing t-cell therapy for use in treating disease; cell-based immunotherapeutic treatment by way of genetically modified cells for use in human therapeutics and the treatment of cancer; pharmaceuticals for the treatment of cancer; pharmaceutical preparations in the nature of genetically modified cells, namely, genetically modified immune cells for use in human therapeutics and in the treatment of cancer; pharmaceutical and biological preparations based on gene, genome and cellular editing, modulation, modification, engineering, regulation, repair and therapy for use in human therapeutics, namely, therapeutic pharmaceuticals developed through genome modifications for the treatment of cardiovascular, central nervous system, endocrine, gastrointestinal, genetic immunological, infectious, inflammatory, menopausal, metabolic, autoimmune, musculoskeletal, neurological, ophthalmological, psychiatric, respiratory, urogenital, urological, hematologic and viral diseases and disorders; pharmaceutical preparations, namely, therapeutic pharmaceuticals developed through genome modifications for the treatment of erectile dysfunction, sexual dysfunction, cancer, pain and diabetes; pharmaceutical preparations, namely, therapeutic pharmaceuticals developed through genome modifications, namely, antifungal preparations, dermatological preparations, smoking cessation preparations and tissue repair preparations; engineered nucleic acids, viral vectors, non-viral vectors, gene therapy vectors, gene editing vectors, genetically modified cells, engineered proteins for multiplexed gene editing, mRNA and recombinant adeno-associated virus (AAV) vectors for delivery of therapeutic DNA or mRNA sequences to cells, antibody preparations, CAR T-cell preparations, T-cell preparations, B-cell preparations, Treg preparations, and NK cell preparations, all for clinical use, medical use, clinical laboratory use, and medical laboratory use
research in the fields of genome editing, gene editing, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, genetic disease, gene therapy and cell therapy; pharmaceutical research and development services; Scientific research; scientific research in genetic, medical, pharmaceutical and veterinary fields; scientific research in chemistry, biology, biochemistry, molecular biology, bacteriology; scientific analysis in the field of immunotherapy; scientific research in the field of cellular immunotherapy utilizing chimeric antigen receptor t cells for use in treating cancer
Medical services, namely, cellular immunotherapy treatments utilizing chimeric antigen receptor t cells for use in treating disease, namely, the treatment of cancer
What has happened so far
Steps recorded by the USPTO, newest first.
- Applicant/correspondence changes (non-responsive) entered
- Teas change of correspondence received
- Attorney/dom.rep.revoked and/or appointed
- Teas revoke/app/change addr of atty/dom rep received
- Teas change of owner address received
- Notice of registration confirmation emailed
- Registered-principal register
- Attorney review completed
- Letter of protest evidence reviewed-no further action taken
- Jurisdiction restored to examining attorney
10 earlier steps on the official record.
About PRECISION BIOSCIENCES
Who owns the trademark "PRECISION BIOSCIENCES"?
The USPTO trademark "PRECISION BIOSCIENCES" (application 97117501) is owned by Precision BioSciences, Inc.
What is the status of "PRECISION BIOSCIENCES"?
Its status at the USPTO is: registered.
When was "PRECISION BIOSCIENCES" registered?
It was registered on April 25, 2023.
Get this data via the API
Everything on this page comes from the Signa API. Pull PRECISION BIOSCIENCES and marks like it into your own product with one request.
GET/v1/trademarks/{id}The full record: owners, classes, dates and images
GET/v1/trademarks/{id}/eventsEvery step in the office history
GET/v1/proceedings?trademark_id={id}Oppositions and cancellations against the mark
ID=tm_019d29d7-7ff0-751c-a89a-7265544be230
curl https://api.signa.so/v1/trademarks/$ID \
-H "Authorization: Bearer $SIGNA_API_KEY"{
"id": "tm_019d29d7-7ff0-751c-a89a-7265544be230",
"object": "trademark",
"mark_text": "PRECISION BIOSCIENCES",
"status": {
"primary": "active",
"stage": "registered"
},
"office_code": "US",
"application_number": "97117501",
"filing_date": "2021-11-10",
"nice_classes": [
1,
5,
42,
44
],
"owners": [
{
"name": "Precision BioSciences, Inc.",
"entity_id": "ent_019eb70d-315a-74b8-abe9-63f452e08615"
}
]
}